DWS CROCI Equity Dividend Fund - Class A (KDHAX)
| Fund Assets | 801.62M |
| Expense Ratio | 1.02% |
| Min. Investment | $1,000 |
| Turnover | 100.00% |
| Dividend (ttm) | 7.97 |
| Dividend Yield | 14.17% |
| Dividend Growth | 62.14% |
| Payout Frequency | Quarterly |
| Ex-Dividend Date | Dec 15, 2025 |
| Previous Close | 56.06 |
| YTD Return | 10.01% |
| 1-Year Return | 11.08% |
| 5-Year Return | 53.91% |
| 52-Week Low | 44.42 |
| 52-Week High | 57.00 |
| Beta (5Y) | n/a |
| Holdings | 42 |
| Inception Date | Mar 18, 1988 |
About KDHAX
DWS CROCI Equity Dividend Fund Class A is an open-end mutual fund designed to provide investors with a high total return by investing primarily in large-cap companies with attractive dividend profiles. The fund utilizes the proprietary CROCI (Cash Return on Capital Invested) methodology, a systematic approach aimed at identifying undervalued companies based on rigorous cash flow analysis. By applying this quantitative process, the fund typically selects a concentrated portfolio of approximately 40 stocks, emphasizing companies that offer strong fundamentals and consistent dividend payments. A distinctive feature of the fund is its flexibility to invest up to 20% of assets in foreign securities, allowing for global diversification while maintaining a focus on developed markets. The portfolio spans various sectors, including information technology, utilities, and industrials, reflecting a diversified allocation across industries. DWS CROCI Equity Dividend Fund Class A plays a notable role in the market by providing investors with a disciplined, valuation-driven approach to dividend investing, targeting companies with sustainable cash flows and robust dividend potential. This focus positions the fund as a strategic choice for those seeking equity income combined with capital appreciation potential.
Performance
KDHAX had a total return of 11.08% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.34%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FVLCX | Fidelity | Fidelity Advisor Value Leaders Fund | 1.90% |
| FSLVX | Fidelity | Fidelity Stock Selector Large Cap Value Fund | 0.83% |
| SWLVX | Schwab | Schwab U.S. Large-Cap Value Index Fund | 0.03% |
| FVLIX | Fidelity | Fidelity Advisor Value Leaders Fund | 0.90% |
| FSCZX | Fidelity | Fidelity Advisor Stock Selector Large Cap Value Fund - Class Z | 0.72% |
Top 10 Holdings
27.54% of assets| Name | Symbol | Weight |
|---|---|---|
| Merck & Co., Inc. | MRK | 2.93% |
| Amgen Inc. | AMGN | 2.91% |
| Coterra Energy Inc. | CTRA | 2.80% |
| Bristol-Myers Squibb Company | BMY | 2.79% |
| Devon Energy Corporation | DVN | 2.79% |
| Tyson Foods, Inc. | TSN | 2.73% |
| Medtronic plc | MDT | 2.73% |
| Johnson & Johnson | JNJ | 2.68% |
| ONEOK, Inc. | OKE | 2.60% |
| Gilead Sciences, Inc. | GILD | 2.57% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 15, 2025 | $6.9443 | Dec 16, 2025 |
| Sep 23, 2025 | $0.4111 | Sep 24, 2025 |
| Jun 23, 2025 | $0.3249 | Jun 24, 2025 |
| Mar 24, 2025 | $0.2919 | Mar 25, 2025 |
| Dec 16, 2024 | $3.8082 | Dec 17, 2024 |
| Sep 23, 2024 | $0.403 | Sep 24, 2024 |